Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Apr;106(Suppl 2):541–557. doi: 10.1289/ehp.98106541

Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.

R E Parchment 1
PMCID: PMC1533375  PMID: 9599702

Abstract

Hematopoietic tissues are the targets of numerous xenobiotics. Clinical hematotoxicity is either a decrease or an increase in peripheral blood cell counts in one or more cell lineages--a cytopenia or a cytosis, respectively--that carries a risk of an adverse clinical event. The purpose of in vitro hematotoxicology is the prediction of these adverse hematologic effects from the effects of the toxicants on human hematopoietic targets under controlled experimental conditions in the laboratory. Building on its important foundations in experimental hematology and the wealth of hematotoxicology data found in experimental oncology, this field of alternative toxicology has developed rapidly during the past decade. Although the colony-forming unit-granulocyte/monocyte neutrophil progenitor is most frequently evaluated, other defined progenitors and stem cells as well as cell types found in the marrow stroma can be evaluated in vitro. End points have been proposed for predicting toxicant exposure levels at the maximum tolerated dose and the no observable adverse effect level for the neutrophil lineage, and several clinical prediction models for neutropenia have developed to the point that they are ready for prospective evaluation and validation in both preclinical species and humans. Known predictive end points are the key to successful comparisons across species or across chemical structures when in vitro dose-response curves are nonparallel. Analytical chemistry support is critical for accurate interpretation of in vitro data and for relating the in vitro pharmacodynamics to the in vivo pharmacokinetics. In contrast to acute neutropenia, anemia and acute thrombocytopenia, as well as adverse effects from chronic toxicant exposure, are much more difficult to predict from in vitro data. Pharmacologic principles critical for clinical predictions from in vitro data very likely will apply to toxicities to other proliferative tissues, such as mucositis.

Full text

PDF
541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham N. G., Bucher D., Niranjan U., Brown A. C., Lutton J. D., Distenfeld A., Ahmed T., Levere R. D. Microenvironmental toxicity of azidothymidine: partial sparing with hemin. Blood. 1989 Jul;74(1):139–144. [PubMed] [Google Scholar]
  2. Aizawa S., Yaguchi M., Nakano M., Toyama K., Inokuchi S., Imai T., Yasuda M., Nabeshima R., Handa H. Hematopoietic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Exp Hematol. 1994 Jun;22(6):482–487. [PubMed] [Google Scholar]
  3. Aymard J. P., Rouveix B., Ferry R., Janot C., May T., Legras B., Streiff F. Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cells. Acta Haematol. 1989;82(1):40–42. doi: 10.1159/000205276. [DOI] [PubMed] [Google Scholar]
  4. Aymard J. P., Wioland C., Ferry R., Netter P., Streiff F. The in vitro effect of amodiaquine on bone marrow granulocyte-macrophage progenitor cells from normal subjects. Fundam Clin Pharmacol. 1992;6(1):1–4. doi: 10.1111/j.1472-8206.1992.tb00086.x. [DOI] [PubMed] [Google Scholar]
  5. Baines P., Bol S., Rosendaal M. Characterization of a developmentally early macrophage progenitor found in normal mouse marrow. Br J Haematol. 1981 May;48(1):147–153. doi: 10.1111/j.1365-2141.1981.00147.x. [DOI] [PubMed] [Google Scholar]
  6. Baines P., Lajmanovich A., Hollard D. Enrichment of high proliferation potential colony forming cells from mouse marrow by selecting low-density cells expressing receptors for wheat germ agglutinin. Leuk Res. 1984;8(5):853–861. doi: 10.1016/0145-2126(84)90106-1. [DOI] [PubMed] [Google Scholar]
  7. Balis F. M., Pizzo P. A., Eddy J., Wilfert C., McKinney R., Scott G., Murphy R. F., Jarosinski P. F., Falloon J., Poplack D. G. Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr. 1989 May;114(5):880–884. doi: 10.1016/s0022-3476(89)80158-1. [DOI] [PubMed] [Google Scholar]
  8. Ben-Ishay Z., Prindull G., Sharon S., Borenstein A. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D. Leuk Res. 1985;9(8):1059–1067. doi: 10.1016/0145-2126(85)90077-3. [DOI] [PubMed] [Google Scholar]
  9. Bender J. G., Lum L., Unverzagt K. L., Lee W., Van Epps D., George S., Coon J., Ghalie R., McLeod B., Kaizer H. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant. 1994 Apr;13(4):479–485. [PubMed] [Google Scholar]
  10. Berardi A. C., Wang A., Levine J. D., Lopez P., Scadden D. T. Functional isolation and characterization of human hematopoietic stem cells. Science. 1995 Jan 6;267(5194):104–108. doi: 10.1126/science.7528940. [DOI] [PubMed] [Google Scholar]
  11. Betticher D. C., Huxol H., Müller R., Speck B., Nissen C. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Exp Hematol. 1993 Nov;21(12):1517–1521. [PubMed] [Google Scholar]
  12. Bhalla K., Birkhofer M., Grant S., Graham G. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol. 1989 Jan;17(1):17–20. [PubMed] [Google Scholar]
  13. Bloom J. C., Thiem P. A., Sellers T. S., Deldar A., Lewis H. B. Cephalosporin-induced immune cytopenia in the dog: demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone. Am J Hematol. 1988 Jun;28(2):71–78. doi: 10.1002/ajh.2830280202. [DOI] [PubMed] [Google Scholar]
  14. Boggs D. R., Joyce R. A. The hematopoietic effects of lithium. Semin Hematol. 1983 Apr;20(2):129–138. [PubMed] [Google Scholar]
  15. Boorman G. A., Luster M. I., Dean J. H., Campbell M. L. Assessment of myelotoxicity caused by environmental chemicals. Environ Health Perspect. 1982 Feb;43:129–135. doi: 10.1289/ehp.8243129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Boswell H. S., Wade P. M., Jr, Quesenberry P. J. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential. J Immunol. 1984 Dec;133(6):2940–2949. [PubMed] [Google Scholar]
  17. Bradley T. R., Hodgson G. S. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood. 1979 Dec;54(6):1446–1450. [PubMed] [Google Scholar]
  18. Bradley T. R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966 Jun;44(3):287–299. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
  19. Breems D. A., Blokland E. A., Neben S., Ploemacher R. E. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia. 1994 Jul;8(7):1095–1104. [PubMed] [Google Scholar]
  20. Broudy V. C., Lin N. L., Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood. 1995 Apr 1;85(7):1719–1726. [PubMed] [Google Scholar]
  21. Broxmeyer H. E., Lu L., Platzer E., Feit C., Juliano L., Rubin B. Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol. 1983 Sep;131(3):1300–1305. [PubMed] [Google Scholar]
  22. Bruce W. R., Meeker B. E., Valeriote F. A. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966 Aug;37(2):233–245. [PubMed] [Google Scholar]
  23. Bungart B., Loeffler M., Goris H., Dontje B., Diehl V., Nijhof W. Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol. 1990 Oct;76(2):174–179. doi: 10.1111/j.1365-2141.1990.tb07868.x. [DOI] [PubMed] [Google Scholar]
  24. Burke T. G., Mi Z. Preferential binding of the carboxylate form of camptothecin by human serum albumin. Anal Biochem. 1993 Jul;212(1):285–287. doi: 10.1006/abio.1993.1325. [DOI] [PubMed] [Google Scholar]
  25. Burke T. G., Mi Z. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J Med Chem. 1994 Jan 7;37(1):40–46. doi: 10.1021/jm00027a005. [DOI] [PubMed] [Google Scholar]
  26. Burke T. G., Munshi C. B., Mi Z., Jiang Y. The important role of albumin in determining the relative human blood stabilities of the camptothecin anticancer drugs. J Pharm Sci. 1995 Apr;84(4):518–519. doi: 10.1002/jps.2600840426. [DOI] [PubMed] [Google Scholar]
  27. Bursuker I., Neddermann K. M., Petty B. A., Schacter B., Spitalny G. L., Tepper M. A., Pasternak R. D. In vivo regulation of hemopoiesis by transforming growth factor beta 1: stimulation of GM-CSF- and M-CSF-dependent murine bone marrow precursors. Exp Hematol. 1992 May;20(4):431–435. [PubMed] [Google Scholar]
  28. Cashman J. D., Eaves A. C., Raines E. W., Ross R., Eaves C. J. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta. Blood. 1990 Jan 1;75(1):96–101. [PubMed] [Google Scholar]
  29. Caux C., Moreau I., Saeland S., Banchereau J. Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells. Blood. 1992 May 15;79(10):2628–2635. [PubMed] [Google Scholar]
  30. Chang J., Geary C. G., Testa N. G. Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br J Haematol. 1990 May;75(1):68–72. doi: 10.1111/j.1365-2141.1990.tb02617.x. [DOI] [PubMed] [Google Scholar]
  31. Chatelain C., Burstein S. A., Harker L. A. Lithium enhancement of megakaryocytopoiesis in culture: mediation via accessory marrow cells. Blood. 1983 Jul;62(1):172–176. [PubMed] [Google Scholar]
  32. Choi K. W., Bloom A. D. Cloning human lymphocytes in vitro. Nature. 1970 Jul 11;227(5254):171–173. doi: 10.1038/227171a0. [DOI] [PubMed] [Google Scholar]
  33. Clarke B. J., Housman D. Characterization of an erythroid precursor cell of high proliferative capacity in normal human peripheral blood. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1105–1109. doi: 10.1073/pnas.74.3.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Collins J. M., Unadkat J. D. Clinical pharmacokinetics of zidovudine. An overview of current data. Clin Pharmacokinet. 1989 Jul;17(1):1–9. doi: 10.2165/00003088-198917010-00001. [DOI] [PubMed] [Google Scholar]
  35. Collins L. S., Dorshkind K. A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol. 1987 Feb 15;138(4):1082–1087. [PubMed] [Google Scholar]
  36. Dainiak N., Worthington M., Riordan M. A., Kreczko S., Goldman L. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol. 1988 Jul;69(3):299–304. doi: 10.1111/j.1365-2141.1988.tb02366.x. [DOI] [PubMed] [Google Scholar]
  37. Dale D. C., Fauci A. S., Guerry D I. V., Wolff S. M. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest. 1975 Oct;56(4):808–813. doi: 10.1172/JCI108159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Deldar A., Lewis H., Bloom J., Weiss L. Reproducible cloning assays for in vitro growth of canine hematopoietic progenitor cells and their potential applications in investigative hematotoxicity. Am J Vet Res. 1988 Aug;49(8):1393–1401. [PubMed] [Google Scholar]
  39. Deldar A., Stevens C. E., Beineke P. J. Comparative distribution of marrow CFU-e and CFU-gm progenitors in different anatomic sites in the dog. Int J Cell Cloning. 1990 May;8(3):196–208. doi: 10.1002/stem.5530080306. [DOI] [PubMed] [Google Scholar]
  40. Deldar A., Stevens C. E. Development and application of in vitro models of hematopoiesis to drug development. Toxicol Pathol. 1993;21(2):231–240. doi: 10.1177/019262339302100216. [DOI] [PubMed] [Google Scholar]
  41. Deldar A., Stevens C. E., Rodocker K. B. Canine BFU-e progenitors: adaptation of a reproducible assay and anatomical distribution. Int J Cell Cloning. 1991 Nov;9(6):579–593. doi: 10.1002/stem.5530090608. [DOI] [PubMed] [Google Scholar]
  42. Demirer T., Rowley S., Buckner C. D., Appelbaum F. R., Lilleby K., Storb R., Schiffman K., Bensinger W. I. Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol. 1995 Jul;13(7):1714–1719. doi: 10.1200/JCO.1995.13.7.1714. [DOI] [PubMed] [Google Scholar]
  43. Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1977 Jun;91(3):335–344. doi: 10.1002/jcp.1040910303. [DOI] [PubMed] [Google Scholar]
  44. Dexter T. M. Haemopoiesis in long-term bone marrow cultures. A review. Acta Haematol. 1979;62(5-6):299–305. doi: 10.1159/000207593. [DOI] [PubMed] [Google Scholar]
  45. Domenech J., Gihana E., Dayan A., Truglio D., Linassier C., Desbois I., Lamagnere J. P., Colombat P., Binet C. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture. Br J Haematol. 1994 Nov;88(3):488–496. doi: 10.1111/j.1365-2141.1994.tb05064.x. [DOI] [PubMed] [Google Scholar]
  46. Dorshkind K. In vitro differentiation of B lymphocytes from primitive hemopoietic precursors present in long-term bone marrow cultures. J Immunol. 1986 Jan;136(2):422–429. [PubMed] [Google Scholar]
  47. Dorshkind K., Johnson A., Harrison Y., Landreth K. S. A colony assay system that detects B cell progenitors in fresh and cultured bone marrow. J Immunol Methods. 1989 Sep 29;123(1):93–101. doi: 10.1016/0022-1759(89)90033-1. [DOI] [PubMed] [Google Scholar]
  48. Douer D., Eisenstein Z. Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient's serum. Eur J Haematol. 1988 Jan;40(1):91–94. doi: 10.1111/j.1600-0609.1988.tb00803.x. [DOI] [PubMed] [Google Scholar]
  49. Du D. L., Volpe D. A., Grieshaber C. K., Murphy M. J., Jr Comparative toxicity of fostriecin, hepsulfam and pyrazine diazohydroxide to human and murine hematopoietic progenitor cells in vitro. Invest New Drugs. 1991 May;9(2):149–157. doi: 10.1007/BF00175082. [DOI] [PubMed] [Google Scholar]
  50. Du D. L., Volpe D. A., Grieshaber C. K., Murphy M. J., Jr Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro. Cancer Res. 1990 Jul 1;50(13):4038–4043. [PubMed] [Google Scholar]
  51. Du D. L., Volpe D. A., Grieshaber C. K., Murphy M. J., Jr In vitro myelotoxicity of 2',3'-dideoxynucleosides on human hematopoietic progenitor cells. Exp Hematol. 1990 Aug;18(7):832–836. [PubMed] [Google Scholar]
  52. Du D. L., Volpe D. A., Murphy M. J., Jr Microcapillary clonogenic assays for human marrow hematopoietic progenitor cells. Int J Cell Cloning. 1989 Sep;7(5):303–313. doi: 10.1002/stem.5530070607. [DOI] [PubMed] [Google Scholar]
  53. Eaves C. J., Sutherland H. J., Udomsakdi C., Lansdorp P. M., Szilvassy S. J., Fraser C. C., Humphries R. K., Barnett M. J., Phillips G. L., Eaves A. C. The human hematopoietic stem cell in vitro and in vivo. Blood Cells. 1992;18(2):301–307. [PubMed] [Google Scholar]
  54. Eliason J. F., Van Zant G., Goldwasser E. The relationship of hemoglobin synthesis to erythroid colony and burst formation. Blood. 1979 May;53(5):935–945. [PubMed] [Google Scholar]
  55. Ema H., Suda T., Sakamoto S., Tomonaga T., Tsunoda J., Muroi K., Komatsu N., Miwa A., Ohsaka A., Yoshida M. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma. Jpn J Cancer Res. 1989 Jun;80(6):577–582. doi: 10.1111/j.1349-7006.1989.tb01678.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Erickson-Miller C. L., Ji H., Parchment R. E., Murphy M. J., Jr Megakaryocyte colony-stimulating factor (Meg-CSF) is a unique cytokine specific for the megakaryocyte lineage. Br J Haematol. 1993 Jun;84(2):197–203. doi: 10.1111/j.1365-2141.1993.tb03052.x. [DOI] [PubMed] [Google Scholar]
  57. Erickson-Miller C. L., May R. D., Tomaszewski J., Osborn B., Murphy M. J., Page J. G., Parchment R. E. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemother Pharmacol. 1997;39(5):467–472. doi: 10.1007/s002800050600. [DOI] [PubMed] [Google Scholar]
  58. Fauser A. A., Messner H. A. Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts. Blood. 1979 May;53(5):1023–1027. [PubMed] [Google Scholar]
  59. Fibbe W. E., Claas F. H., Van der Star-Dijkstra W., Schaafsma M. R., Meyboom R. H., Falkenburg J. H. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol. 1986 Oct;64(2):363–373. doi: 10.1111/j.1365-2141.1986.tb04130.x. [DOI] [PubMed] [Google Scholar]
  60. Fink F. M., Maurer-Dengg K., Fritsch G., Mann G., Zoubek A., Falk M., Gadner H. Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery. Med Pediatr Oncol. 1995 Nov;25(5):365–371. doi: 10.1002/mpo.2950250502. [DOI] [PubMed] [Google Scholar]
  61. Friedenstein A. J., Chailakhyan R. K., Latsinik N. V., Panasyuk A. F., Keiliss-Borok I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974 Apr;17(4):331–340. doi: 10.1097/00007890-197404000-00001. [DOI] [PubMed] [Google Scholar]
  62. Friedenstein A. J., Deriglasova U. F., Kulagina N. N., Panasuk A. F., Rudakowa S. F., Luriá E. A., Ruadkow I. A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2(2):83–92. [PubMed] [Google Scholar]
  63. Gallamini A., Carbone A., Lista P., Cavallero G., Reato G., Fruttero A., Novero D., Asnaghi G., di Celle P. F., Foa R. Intestinal T-cell lymphoma with massive tissue and blood eosinophilia mediated by IL-5. Leuk Lymphoma. 1995 Mar;17(1-2):155–161. [PubMed] [Google Scholar]
  64. Gallini R., Hendry J. H., Molineux G., Testa N. G. The effect of low dose rate on recovery of hemopoietic and stromal progenitor cells in gamma-irradiated mouse bone marrow. Radiat Res. 1988 Sep;115(3):481–487. [PubMed] [Google Scholar]
  65. Ganousis L. G., Goon D., Zyglewska T., Wu K. K., Ross D. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites. Mol Pharmacol. 1992 Dec;42(6):1118–1125. [PubMed] [Google Scholar]
  66. Ganser A., Greher J., Völkers B., Staszewski S., Hoelzer D. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS. Exp Hematol. 1989 May;17(4):321–325. [PubMed] [Google Scholar]
  67. Gartner S., Kaplan H. S. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4756–4759. doi: 10.1073/pnas.77.8.4756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Gerson S. L., Arce C., Meltzer H. Y. N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis. Br J Haematol. 1994 Mar;86(3):555–561. doi: 10.1111/j.1365-2141.1994.tb04786.x. [DOI] [PubMed] [Google Scholar]
  69. Gianni L., Viganò L., Surbone A., Ballinari D., Casali P., Tarella C., Collins J. M., Bonadonna G. Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. J Natl Cancer Inst. 1990 Mar 21;82(6):469–477. doi: 10.1093/jnci/82.6.469. [DOI] [PubMed] [Google Scholar]
  70. Gidáli J., István E., Fehér I. Long-term perturbation of hemopoiesis after moderate damage to stem cells. Exp Hematol. 1985 Aug;13(7):647–651. [PubMed] [Google Scholar]
  71. Grande T., Bueren J. A. Analysis of hematopoiesis in mice irradiated with 500 mGy of X rays at different stages of development. Radiat Res. 1995 Sep;143(3):327–333. [PubMed] [Google Scholar]
  72. Grande T., Bueren J. A. Involvement of the bone marrow stroma in the residual hematopoietic damage induced by irradiation of adult and young mice. Exp Hematol. 1994 Dec;22(13):1283–1287. [PubMed] [Google Scholar]
  73. Grande T., Gaitán S., Tejero C., Bueren J. A. Residual haematopoietic damage in adult and 8 day-old mice exposed to 7 Gy of X-rays. Int J Radiat Biol. 1993 Jan;63(1):59–67. doi: 10.1080/09553009314550081. [DOI] [PubMed] [Google Scholar]
  74. Greenberg P. L., Schrier S. L. Clinical utility of in vitro evaluation of granulopoiesis. Annu Rev Med. 1974;25:269–278. doi: 10.1146/annurev.me.25.020174.001413. [DOI] [PubMed] [Google Scholar]
  75. Greenberg P., Bax I., Mara B., Schrier S. Alterations of granulopoiesis following chemotherapy. Blood. 1974 Sep;44(3):375–383. [PubMed] [Google Scholar]
  76. Greenberger J. S. Toxic effects on the hematopoietic microenvironment. Exp Hematol. 1991 Dec;19(11):1101–1109. [PubMed] [Google Scholar]
  77. Gregory C. J., Eaves A. C. Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses. Blood. 1977 Jun;49(6):855–864. [PubMed] [Google Scholar]
  78. Grillot-Courvalin C., Vinci G., Tsapis A., Dokhelar M. C., Vainchenker W., Brouet J. C. The syndrome of T8 hyperlymphocytosis: variation in phenotype and cytotoxic activities of granular cells and evaluation of their role in associated neutropenia. Blood. 1987 Apr;69(4):1204–1210. [PubMed] [Google Scholar]
  79. Hara H., Ogawa M. Erthropoietic precursors in mice with phenylhydrazine-induced anemia. Am J Hematol. 1976;1(4):453–458. doi: 10.1002/ajh.2830010410. [DOI] [PubMed] [Google Scholar]
  80. Hara H., Ogawa M. Murine hemopoietic colonies in culture containing normoblasts, macrophages, and megakaryocytes. Am J Hematol. 1978;4(1):23–34. doi: 10.1002/ajh.2830040105. [DOI] [PubMed] [Google Scholar]
  81. Hargis J. B., La Russa V. F., Redmond J., Kessler S. W., Wright D. G. Agranulocytosis associated with "Mexican aspirin" (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors. Am J Hematol. 1989 Jul;31(3):213–215. doi: 10.1002/ajh.2830310314. [DOI] [PubMed] [Google Scholar]
  82. Hauser S. P., Udupa K. B., Lipschitz D. A. Effects of ceftazidime, a betalactam antibiotic, on murine haemopoiesis in vitro. Br J Haematol. 1994 Apr;86(4):733–739. doi: 10.1111/j.1365-2141.1994.tb04822.x. [DOI] [PubMed] [Google Scholar]
  83. Haworth C., Morris-Jones P. H., Testa N. G. Long-term bone-marrow damage in children treated for ALL: evidence from in vitro colony assays (GM-CFC and CFUF). Br J Cancer. 1982 Dec;46(6):918–923. doi: 10.1038/bjc.1982.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Hendricks C. B., Grochow L. B., Rowinsky E. K., Forastiere A. A., McGuire W. P., Ettinger D. S., Sartorius S., Lubejko B., Donehower R. C. Phase I and pharmacokinetic study of hepsulfam (NSC 329680). Cancer Res. 1991 Nov 1;51(21):5781–5785. [PubMed] [Google Scholar]
  85. Hendry J. H., Wang S. B., Testa N. G. Greater sparing of stromal progenitor cells than of haemopoietic stem cells in gamma-irradiated mouse marrow using low dose-rates. Biomed Pharmacother. 1984;38(7):356–358. [PubMed] [Google Scholar]
  86. Hodgson G. S., Bradley T. R., Radley J. M. The organization of hemopoietic tissue as inferred from the effects of 5-fluorouracil. Exp Hematol. 1982 Jan;10(1):26–35. [PubMed] [Google Scholar]
  87. Holberg-Petersen M., Rollag H., Beck S., Overli I., Tjønnfjord G., Abrahamsen T. G., Degré M., Hestdal K. Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro. Blood. 1996 Oct 1;88(7):2510–2516. [PubMed] [Google Scholar]
  88. Horikoshi A., Murphy M. J., Jr Comparative effects of chemotherapeutic drugs on human and murine hematopoietic progenitors in vitro. Chemotherapy. 1982;28(6):480–501. doi: 10.1159/000238139. [DOI] [PubMed] [Google Scholar]
  89. Humphrey C. A., French A., Morris T. C. Prospective in vitro testing for drug-induced neutropenia in a patient requiring anti-malarial prophylaxis: confirmation of findings on exposure of patient to drug. Clin Lab Haematol. 1990;12(1):31–36. doi: 10.1111/j.1365-2257.1990.tb01107.x. [DOI] [PubMed] [Google Scholar]
  90. Ichikawa Y., Pluznik D. H., Sachs L. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A. 1966 Aug;56(2):488–495. doi: 10.1073/pnas.56.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Inoue T., Tsushita K., Itoh T., Ogura M., Hotta T., Saneyoshi M., Yoshida S., Saitoh H., Tomoda Y., Nagai Y. In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus. Antimicrob Agents Chemother. 1989 Apr;33(4):576–579. doi: 10.1128/aac.33.4.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Irvine A. E., Morris T. C., Kelly G. J., McCracken N. Ticarcillin-induced neutropenia corroborated by in vitro CFU-C toxicity. Acta Haematol. 1983;70(6):364–368. doi: 10.1159/000206794. [DOI] [PubMed] [Google Scholar]
  93. Iscove N. N., Sieber F. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Hematol. 1975 Jan;3(1):32–43. [PubMed] [Google Scholar]
  94. Jacobsen S. E., Keller J. R., Ruscetti F. W., Kondaiah P., Roberts A. B., Falk L. A. Bidirectional effects of transforming growth factor beta (TGF-beta) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-beta isoforms. Blood. 1991 Nov 1;78(9):2239–2247. [PubMed] [Google Scholar]
  95. Johnson A., Dorshkind K. Stromal cells in myeloid and lymphoid long-term bone marrow cultures can support multiple hemopoietic lineages and modulate their production of hemopoietic growth factors. Blood. 1986 Dec;68(6):1348–1354. [PubMed] [Google Scholar]
  96. Johnson G. R. Colony formation in agar by adult bone marrow multipotential hemopoietic cells. J Cell Physiol. 1980 Jun;103(3):371–383. doi: 10.1002/jcp.1041030302. [DOI] [PubMed] [Google Scholar]
  97. Johnson G. R., Metcalf D. Nature of cells forming erythroid colonies in agar after stimulation by spleen conditioned medium. J Cell Physiol. 1978 Mar;94(3):243–252. doi: 10.1002/jcp.1040940302. [DOI] [PubMed] [Google Scholar]
  98. Johnson G. R., Metcalf D. Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3879–3882. doi: 10.1073/pnas.74.9.3879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Kalechman Y., Rushkin G., Nerubay J., Albeck M., Sredni B. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice. Exp Hematol. 1995 Dec;23(13):1358–1366. [PubMed] [Google Scholar]
  100. Kalechman Y., Sotnik-Barkai I., Albeck M., Sredni B. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101). Cancer Res. 1993 Apr 15;53(8):1838–1844. [PubMed] [Google Scholar]
  101. Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen F. S. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994 Jun 16;369(6481):568–571. doi: 10.1038/369568a0. [DOI] [PubMed] [Google Scholar]
  102. Kaushansky K. The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development. Stem Cells. 1994;12 (Suppl 1):91–97. [PubMed] [Google Scholar]
  103. Klein A. K., Dyck J. A., Shimizu J. A., Stitzel K. A., Wilson F. D., Cain G. R. Effect of continuous, whole-body gamma irradiation upon canine lymphohematopoietic (CFU-GM, CFU-L) progenitors and a possible hematopoietic regulatory population. Radiat Res. 1985 Feb;101(2):332–350. [PubMed] [Google Scholar]
  104. Klein A. K., Rosenblatt L. S., Stitzel K. A., Greenberg B., Woo L. In vitro radiation response studies on bone marrow fibroblasts (CFU-F) obtained from normal and chronically irradiated dogs. Leuk Res. 1984;8(3):473–481. doi: 10.1016/0145-2126(84)90088-2. [DOI] [PubMed] [Google Scholar]
  105. Kobashi H., Adachi T., Tsubota T., Asano K., Fukai M., Namba J., Izumi K., Hoshijima T., Miura H., Sezaki T. [The role of drugs and lymphocytes in granulocyte-macrophage colony formation in patients with drug induced agranulocytosis]. Rinsho Ketsueki. 1989 Mar;30(3):282–288. [PubMed] [Google Scholar]
  106. Koury M. J., Kost T. A., Hankins W. D., Krantz S. B. Response of erythroid day 3 burst-forming units to endotoxin and erythropoietin. Proc Soc Exp Biol Med. 1979 Nov;162(2):275–280. doi: 10.3181/00379727-162-40664. [DOI] [PubMed] [Google Scholar]
  107. Leary A. G., Ogawa M. Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors. Blood. 1987 Mar;69(3):953–956. [PubMed] [Google Scholar]
  108. Lemieux M. E., Rebel V. I., Lansdorp P. M., Eaves C. J. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow "switch" cultures. Blood. 1995 Aug 15;86(4):1339–1347. [PubMed] [Google Scholar]
  109. Levitt L. J. Chlorpropamide-induced pure white cell aplasia. Blood. 1987 Feb;69(2):394–400. [PubMed] [Google Scholar]
  110. Levitt L. J., Quesenberry P. J. The effect of lithium on murine hematopoiesis in a liquid culture system. N Engl J Med. 1980 Mar 27;302(13):713–719. doi: 10.1056/NEJM198003273021303. [DOI] [PubMed] [Google Scholar]
  111. Lopez Lopez R., Peters G. J., van Loenen A. C., Pizao P. E., van Rijswijk R. E., Wagstaff J., Pinedo H. M. The effect of schedule, protein binding and growth factors on the activity of suramin. Int J Cancer. 1992 Jul 30;51(6):921–926. doi: 10.1002/ijc.2910510615. [DOI] [PubMed] [Google Scholar]
  112. Léglise M. C., Darodes de Tailly P., Vignot J. L., Le Bot M. A., Le Roux A. M., Riché C. A cellular model for drug interactions on hematopoiesis: the use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis. Cell Biol Toxicol. 1996 Feb;12(1):39–53. doi: 10.1007/BF00143393. [DOI] [PubMed] [Google Scholar]
  113. Macdonald D., Gordon A. A., Kajitani H., Enokihara H., Barrett A. J. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production. Br J Haematol. 1990 Oct;76(2):168–173. doi: 10.1111/j.1365-2141.1990.tb07867.x. [DOI] [PubMed] [Google Scholar]
  114. Marsh J. C. Chemical toxicity of the granulocyte. Environ Health Perspect. 1981 Jun;39:71–78. doi: 10.1289/ehp.813971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Matsuzaki M., Tokioka T., Suga K., Sueoka E., Ono K., Sano M., Shimamoto Y., Yamaguchi M. [Phenytoin induced agranulocytosis: direct and T cell-mediated mechanisms]. Rinsho Ketsueki. 1990 Apr;31(4):474–478. [PubMed] [Google Scholar]
  116. McNiece I. K., Bertoncello I., Kriegler A. B., Quesenberry P. J. Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning. 1990 May;8(3):146–160. doi: 10.1002/stem.5530080302. [DOI] [PubMed] [Google Scholar]
  117. McNiece I. K., Stewart F. M., Deacon D. M., Temeles D. S., Zsebo K. M., Clark S. C., Quesenberry P. J. Detection of a human CFC with a high proliferative potential. Blood. 1989 Aug 1;74(2):609–612. [PubMed] [Google Scholar]
  118. Mei R. L., Burstein S. A. Megakaryocytic maturation in murine long-term bone marrow culture: role of interleukin-6. Blood. 1991 Sep 15;78(6):1438–1447. [PubMed] [Google Scholar]
  119. Meijne E. I., Ploemacher R. E., Vos O., Huiskamp R. The effects of graded doses of 1 MeV fission neutrons or X rays on the murine hematopoietic stroma. Radiat Res. 1992 Sep;131(3):302–308. [PubMed] [Google Scholar]
  120. Metcalf D., Johnson G. R., Mandel T. E. Colony formation in agar by multipotential hemopoietic cells. J Cell Physiol. 1979 Feb;98(2):401–420. doi: 10.1002/jcp.1040980216. [DOI] [PubMed] [Google Scholar]
  121. Metcalf D., MacDonald H. R., Odartchenko N., Sordat B. Growth of mouse megakaryocyte colonies in vitro. Proc Natl Acad Sci U S A. 1975 May;72(5):1744–1748. doi: 10.1073/pnas.72.5.1744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 1993 Sep 1;82(5):1395–1401. [PubMed] [Google Scholar]
  123. Meytes D., Ma Ortega J. A., Shore N. A., Dukes P. P. Human erythroid burst-promoting activity produced by phytohemagglutinin-stimulated, radioresistant peripheral blood mononuclear cells. Blood. 1979 Nov;54(5):1050–1057. [PubMed] [Google Scholar]
  124. Mi Z., Burke T. G. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry. 1994 Aug 30;33(34):10325–10336. doi: 10.1021/bi00200a013. [DOI] [PubMed] [Google Scholar]
  125. Mi Z., Burke T. G. Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study. Biochemistry. 1994 Oct 25;33(42):12540–12545. doi: 10.1021/bi00208a002. [DOI] [PubMed] [Google Scholar]
  126. Miller V. A., Rigas J. R., Tong W. P., Reid J. R., Pisters K. M., Grant S. C., Heelan R. T., Kris M. G. Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer. Cancer Chemother Pharmacol. 1997;40(5):415–418. doi: 10.1007/s002800050679. [DOI] [PubMed] [Google Scholar]
  127. Morse G. D., Olson J., Portmore A., Taylor C., Plank C., Reichman R. C. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection. Antiviral Res. 1989 Mar;11(2):57–65. doi: 10.1016/0166-3542(89)90008-9. [DOI] [PubMed] [Google Scholar]
  128. Mukai J., Shimizu E., Ogura T. Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens. Jpn J Cancer Res. 1992 Jul;83(7):746–753. doi: 10.1111/j.1349-7006.1992.tb01975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Murray L., DiGiusto D., Chen B., Chen S., Combs J., Conti A., Galy A., Negrin R., Tricot G., Tsukamoto A. Analysis of human hematopoietic stem cell populations. Blood Cells. 1994;20(2-3):364–370. [PubMed] [Google Scholar]
  130. Myers S. R., Flesher J. W. Metabolism of the carcinogen 3-methylcholanthrene in human bone marrow preparations. Drug Metab Dispos. 1990 Sep-Oct;18(5):664–669. [PubMed] [Google Scholar]
  131. Nagasawa R., Kanagawa O., Tittle T. V., Chiller J. M. In vivo maturation of pre-B cells derived from long-term cultured bone marrow. J Immunol. 1985 Aug;135(2):965–972. [PubMed] [Google Scholar]
  132. Nakeff A., Daniels-McQueen S. In vitro colony assay for a new class of megakaryocyte precursor: colony-forming unit megakaryocyte (CFU-M). Proc Soc Exp Biol Med. 1976 Mar;151(3):587–590. doi: 10.3181/00379727-151-39265. [DOI] [PubMed] [Google Scholar]
  133. Naughton B. A., Sibanda B., Azar L., San Roman J. Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow cultures established on nylon screens. Proc Soc Exp Biol Med. 1992 Apr;199(4):481–490. doi: 10.3181/00379727-199-43384. [DOI] [PubMed] [Google Scholar]
  134. Neelis K. J., Dubbelman Y. D., Qingliang L., Thomas G. R., Eaton D. L., Wagemaker G. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol. 1997 Sep;25(10):1084–1093. [PubMed] [Google Scholar]
  135. Nishi N., Nakahata T., Koike K., Takagi M., Naganuma K., Akabane T. Induction of mixed erythroid-megakaryocyte colonies and bipotential blast cell colonies by recombinant human erythropoietin in serum-free culture. Blood. 1990 Oct 1;76(7):1330–1335. [PubMed] [Google Scholar]
  136. Nishihira H., Toyoda Y., Miyazaki H., Kigasawa H., Ohsaki E. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol. 1996 Jan;92(1):23–28. doi: 10.1046/j.1365-2141.1996.00287.x. [DOI] [PubMed] [Google Scholar]
  137. Ogata K., Erickson-Miller C. L., Nomura T., Abe K., Zhang Z., Murphy M. J., Jr Effects of recombinant cytokines on murine megakaryocyte colony formation in a serum-free fibrin clot culture system. Pathobiology. 1992;60(3):143–148. doi: 10.1159/000163713. [DOI] [PubMed] [Google Scholar]
  138. Ono K., Kurohara K., Yoshihara M., Shimamoto Y., Yamaguchi M. Agranulocytosis caused by ticlopidine and its mechanism. Am J Hematol. 1991 Aug;37(4):239–242. doi: 10.1002/ajh.2830370405. [DOI] [PubMed] [Google Scholar]
  139. Orlic D., Anderson S., Bodine D. M. Biological properties of subpopulations of pluripotent hematopoietic stem cells enriched by elutriation and flow cytometry. Blood Cells. 1994;20(1):107–120. [PubMed] [Google Scholar]
  140. Orlic D., Fischer R., Nishikawa S., Nienhuis A. W., Bodine D. M. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood. 1993 Aug 1;82(3):762–770. [PubMed] [Google Scholar]
  141. Parchment R. E., Huang M., Erickson-Miller C. L. Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning. Toxicol Pathol. 1993;21(2):241–250. doi: 10.1177/019262339302100217. [DOI] [PubMed] [Google Scholar]
  142. Parchment R. E., Volpe D. A., LoRusso P. M., Erickson-Miller C. L., Murphy M. J., Jr, Grieshaber C. K. In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrow. J Natl Cancer Inst. 1994 Feb 16;86(4):273–280. doi: 10.1093/jnci/86.4.273. [DOI] [PubMed] [Google Scholar]
  143. Parent-Massin D. M., Sensébé L., Léglise M. C., Guern G., Berthou C., Riché C., Abgrall J. F. Relevance of in vitro studies of drug-induced agranulocytosis. Report of 14 cases. Drug Saf. 1993 Dec;9(6):463–469. doi: 10.2165/00002018-199309060-00009. [DOI] [PubMed] [Google Scholar]
  144. Parent-Massin D., Fuselier R., Thouvenot D. In vitro toxicity of trichothecenes on human haematopoietic progenitors. Food Addit Contam. 1994 Jul-Aug;11(4):441–447. doi: 10.1080/02652039409374246. [DOI] [PubMed] [Google Scholar]
  145. Parent-Massin D., Thouvenot D. In vitro study of pesticide hematotoxicity in human and rat progenitors. J Pharmacol Toxicol Methods. 1993 Dec;30(4):203–207. doi: 10.1016/1056-8719(93)90018-a. [DOI] [PubMed] [Google Scholar]
  146. Parmentier C., Tchernia G., Subtil E., Diakhate L., Morardet N. In vitro medullary granulocytic progenitor (CFUc) cultures from 6 cases of granulocytopenias. Scand J Haematol. 1978 Jul;21(1):19–23. doi: 10.1111/j.1600-0609.1978.tb02490.x. [DOI] [PubMed] [Google Scholar]
  147. Pessina A., Neri M. G., Muschiato A., Mineo E., Cocuzza G. Effect of fluoroquinolones on the in-vitro proliferation of myeloid precursor cells. J Antimicrob Chemother. 1989 Aug;24(2):203–208. doi: 10.1093/jac/24.2.203. [DOI] [PubMed] [Google Scholar]
  148. Pessina A., Neri M. G., Muschiato A., Raimondi A. Inhibition of granulocytic-macrophagic precursor cells (CFU-C) by heat-labile enterotoxin (LT) produced by Escherichia coli. Biomed Pharmacother. 1983;37(9-10):447–452. [PubMed] [Google Scholar]
  149. Pettengell R., Luft T., Henschler R., Hows J. M., Dexter T. M., Ryder D., Testa N. G. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood. 1994 Dec 1;84(11):3653–3659. [PubMed] [Google Scholar]
  150. Piacibello W., Ferrero D., Sanavio F., Badoni R., Stacchini A., Severino A., Aglietta M. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Exp Hematol. 1991 Dec;19(11):1084–1089. [PubMed] [Google Scholar]
  151. Pisciotta A. V., Konings S. A., Ciesemier L. L., Cronkite C. E., Lieberman J. A. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis. J Lab Clin Med. 1992 Mar;119(3):254–266. [PubMed] [Google Scholar]
  152. Pisciotta A. V., Konings S. A., Ciesemier L. L., Cronkite C. E., Lieberman J. A. On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Saf. 1992;7 (Suppl 1):33–44. doi: 10.2165/00002018-199200071-00009. [DOI] [PubMed] [Google Scholar]
  153. Ploemacher R. E., Brons R. H. Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell. Exp Hematol. 1989 Mar;17(3):263–266. [PubMed] [Google Scholar]
  154. Ploemacher R. E., van der Sluijs J. P., Voerman J. S., Brons N. H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 1989 Dec;74(8):2755–2763. [PubMed] [Google Scholar]
  155. Pluznik D. H., Sachs L. The cloning of normal "mast" cells in tissue culture. J Cell Physiol. 1965 Dec;66(3):319–324. doi: 10.1002/jcp.1030660309. [DOI] [PubMed] [Google Scholar]
  156. Ponassi A., Morra L., Mela G. S., Caristo G., Parodi G. B., Sacchetti C. Correlation between blood granulocyte progenitor cells and polymorphonuclear leukocytes. A tentative pathophysiological subgrouping of neutropenic and neutrophilic patients. Biomed Pharmacother. 1983;37(6):293–297. [PubMed] [Google Scholar]
  157. Pressacco J., Erlichman C. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects. Biochem Pharmacol. 1993 Dec 3;46(11):1989–1997. doi: 10.1016/0006-2952(93)90641-9. [DOI] [PubMed] [Google Scholar]
  158. Pressacco J., Hedley D. W., Erlichman C. ICI D1694 and idoxuridine: a synergistic antitumor combination. Cancer Res. 1994 Jul 15;54(14):3772–3778. [PubMed] [Google Scholar]
  159. Qi D. Y., Hendry J. H., Testa N. G. Interactions in recovery and in residual injury from sequential treatments of mouse haemopoietic and stromal marrow cell populations, using X-rays, cyclophosphamide and busulphan. Radiother Oncol. 1991 Jan;20(1):46–52. doi: 10.1016/0167-8140(91)90111-s. [DOI] [PubMed] [Google Scholar]
  160. Radford J. A., Testa N. G., Crowther D. The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function. Br J Cancer. 1990 Jul;62(1):127–132. doi: 10.1038/bjc.1990.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Richman D. D., Fischl M. A., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. doi: 10.1056/NEJM198707233170402. [DOI] [PubMed] [Google Scholar]
  162. Ruscetti F. W., Dubois C., Falk L. A., Jacobsen S. E., Sing G., Longo D. L., Wiltrout R. H., Keller J. R. In vivo and in vitro effects of TGF-beta 1 on normal and neoplastic haemopoiesis. Ciba Found Symp. 1991;157:212–231. doi: 10.1002/9780470514061.ch14. [DOI] [PubMed] [Google Scholar]
  163. Schreml W., Lohrmann H. P. No effects of levamisole on cytotoxic drug-induced changes of human granulopoiesis. Blut. 1979 Apr 20;38(4):331–336. doi: 10.1007/BF01008147. [DOI] [PubMed] [Google Scholar]
  164. Schurig J. E., Schlein A., Florczyk A. P., Farwell A. R., Bradner W. T. Animal models for evaluating the myelosuppressive effects of cancer chemotherapeutic agents. Exp Hematol. 1985;13 (Suppl 16):101–105. [PubMed] [Google Scholar]
  165. Seed T. M., Kaspar L. V. Changing patterns of radiosensitivity of hematopoietic progenitors from chronically irradiated dogs prone either to aplastic anemia or to myeloproliferative disease. Leuk Res. 1990;14(4):299–307. doi: 10.1016/0145-2126(90)90156-4. [DOI] [PubMed] [Google Scholar]
  166. Silberstein D. S., Austen K. F., Owen W. F., Jr Hemopoietins for eosinophils. Glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated disease. Hematol Oncol Clin North Am. 1989 Sep;3(3):511–533. [PubMed] [Google Scholar]
  167. Smith A. C., Liao J. T., Page J. G., Wientjes M. G., Grieshaber C. K. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Cancer Res. 1989 Oct 1;49(19):5385–5391. [PubMed] [Google Scholar]
  168. Smith J. G., Smith M. A., James I., Blundell E., Maddison P. J. Inhibition of CFU-GM by prostaglandins in a case of chronic T-cell lymphocytosis and neutropenia. Br J Haematol. 1989 Oct;73(2):148–151. doi: 10.1111/j.1365-2141.1989.tb00244.x. [DOI] [PubMed] [Google Scholar]
  169. Song D., Hsu L. F., Au J. L. Binding of taxol to plastic and glass containers and protein under in vitro conditions. J Pharm Sci. 1996 Jan;85(1):29–31. doi: 10.1021/js950286j. [DOI] [PubMed] [Google Scholar]
  170. Sonoda Y., Maekawa T., Kuzuyama Y., Clark S. C., Abe T. Human interleukin-9 supports formation of a subpopulation of erythroid bursts that are responsive to interleukin-3. Am J Hematol. 1992 Oct;41(2):84–91. doi: 10.1002/ajh.2830410204. [DOI] [PubMed] [Google Scholar]
  171. Sperner-Unterweger B., Gaggl S., Fleischhacker W. W., Barnas C., Herold M., Geissler D. Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry. 1993 Oct 15;34(8):536–543. doi: 10.1016/0006-3223(93)90196-k. [DOI] [PubMed] [Google Scholar]
  172. Stephenson J. R., Axelrad A. A., McLeod D. L., Shreeve M. M. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1542–1546. doi: 10.1073/pnas.68.7.1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Stojanović N., Ruvidić R., Jovcić G., Mijović A. Drug-induced agranulocytosis: bone marrow granulocytic progenitor cells. Biomed Pharmacother. 1990;44(3):181–184. doi: 10.1016/0753-3322(90)90007-v. [DOI] [PubMed] [Google Scholar]
  174. Strife A., Lambek C., Perez A., Darzynkiewicz Z., Skierski J., Gulati S., Haley J. D., ten Dijke P., Iwata K. K., Clarkson B. D. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Cancer Res. 1991 Sep 15;51(18):4828–4836. [PubMed] [Google Scholar]
  175. Sutherland H. J., Lansdorp P. M., Henkelman D. H., Eaves A. C., Eaves C. J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A. 1990 May;87(9):3584–3588. doi: 10.1073/pnas.87.9.3584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Thomas D. J., Sadler A., Subrahmanyam V. V., Siegel D., Reasor M. J., Wierda D., Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol Pharmacol. 1990 Feb;37(2):255–262. [PubMed] [Google Scholar]
  177. Till J. E., Price G. B., Mak T. W., McCulloch E. A. Regulation of blood cell diferentiation. Fed Proc. 1975 Dec;34(13):2279–2284. [PubMed] [Google Scholar]
  178. Treleaven J., Barrett J. Drugs and the bone marrow. Br J Hosp Med. 1990 Oct;44(4):245–250. [PubMed] [Google Scholar]
  179. Twerdok L. E., Mosebrook D. R., Trush M. A. Comparison of oxidant-generation and BP-diol activation by bone marrow cells from C57Bl/6 and DBA/2 mice: implications for risk of bone marrow toxicity induced by polycyclic hydrocarbons. Toxicol Appl Pharmacol. 1992 Feb;112(2):266–272. doi: 10.1016/0041-008x(92)90196-y. [DOI] [PubMed] [Google Scholar]
  180. Twerdok L. E., Rembish S. J., Trush M. A. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: effect on hydroquinone-induced cytotoxicity. Toxicol Appl Pharmacol. 1992 Feb;112(2):273–281. doi: 10.1016/0041-008x(92)90197-z. [DOI] [PubMed] [Google Scholar]
  181. Twerdok L. E., Trush M. A. Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res Commun Chem Pathol Pharmacol. 1990 Mar;67(3):375–386. [PubMed] [Google Scholar]
  182. Twerdok L. E., Trush M. A. Studies on biochemical determinants of quinone-induced toxicity in primary murine bone marrow stromal cells. Adv Exp Med Biol. 1991;283:843–846. doi: 10.1007/978-1-4684-5877-0_118. [DOI] [PubMed] [Google Scholar]
  183. Urashima M., Uchiyama H., Hoshi Y., Deguchi Y., Kamijou M., Katou Y., Fujisawa K., Akatsuka J., Maekawa K. Prediction of engraftment after peripheral blood stem cell transplantation by CD34-positive cells in grafts. Acta Paediatr Jpn. 1993 Aug;35(4):325–331. doi: 10.1111/j.1442-200x.1993.tb03063.x. [DOI] [PubMed] [Google Scholar]
  184. Vainchenker W., Bouguet J., Guichard J., Breton-Gorius J. Megakaryocyte colony formation from human bone marrow precursors. Blood. 1979 Oct;54(4):940–945. [PubMed] [Google Scholar]
  185. Valeriote F., van Putten L. Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer Res. 1975 Oct;35(10):2619–2630. [PubMed] [Google Scholar]
  186. Van Den Heuvel R., Schoeters G., Leppens H., Vanderborght O. Stromal cells in long-term cultures of liver, spleen, and bone marrow at different developmental ages have different capacities to maintain GM-CFC proliferation. Exp Hematol. 1991 Feb;19(2):115–121. [PubMed] [Google Scholar]
  187. Ventura G. J., Reading C. L., Hester J. P., Vadhan-Raj S. Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration. Acta Haematol. 1990;84(4):175–181. doi: 10.1159/000205058. [DOI] [PubMed] [Google Scholar]
  188. Volpe D. A., Cole K., Sandeen M. A., Kohn E. C. In vitro and in vivo myelotoxicity of CAI to human and murine hematopoietic progenitor cells. Am J Hematol. 1995 Dec;50(4):277–282. doi: 10.1002/ajh.2830500409. [DOI] [PubMed] [Google Scholar]
  189. Volpe D. A., Du D. L., Grieshaber C. K., Murphy M. J., Jr In vitro characterization of the myelotoxicity of cyclopentenyl cytosine. Cancer Chemother Pharmacol. 1994;34(2):103–108. doi: 10.1007/BF00685926. [DOI] [PubMed] [Google Scholar]
  190. Volpe D. A., Du D. L., Pohl K. P., Campbell J. P., Murphy M. J., Jr Utility of human bone marrow obtained incidental to orthopedic surgery for hematopoietic clonal assays. Pathobiology. 1991;59(1):53–56. doi: 10.1159/000163615. [DOI] [PubMed] [Google Scholar]
  191. Volpe D. A., Du D. L., Verhoef V., Murphy M. J., Jr Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro. Pathobiology. 1993;61(2):77–82. doi: 10.1159/000163764. [DOI] [PubMed] [Google Scholar]
  192. Volpe D. A., Du D. L., Zurlo M. G., Mongelli N., Murphy M. J. Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cells. Invest New Drugs. 1992 Nov;10(4):255–261. doi: 10.1007/BF00944178. [DOI] [PubMed] [Google Scholar]
  193. Wagemaker G., Peters M. F., Bol S. J. Induction of erythropoietin responsiveness in vitro by a distinct population of bone marrow cells. Cell Tissue Kinet. 1979 Sep;12(5):521–537. doi: 10.1111/j.1365-2184.1979.tb00174.x. [DOI] [PubMed] [Google Scholar]
  194. Walker R. E., Parker R. I., Kovacs J. A., Masur H., Lane H. C., Carleton S., Kirk L. E., Gralnick H. R., Fauci A. S. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med. 1988 Mar;108(3):372–376. doi: 10.7326/0003-4819-108-3-372. [DOI] [PubMed] [Google Scholar]
  195. Wang T. Y., Brennan J. K., Wu J. H. Multilineal hematopoiesis in a three-dimensional murine long-term bone marrow culture. Exp Hematol. 1995 Jan;23(1):26–32. [PubMed] [Google Scholar]
  196. Watt S. M., Visser J. W. Recent advances in the growth and isolation of primitive human haemopoietic progenitor cells. Cell Prolif. 1992 Jul;25(4):263–297. doi: 10.1111/j.1365-2184.1992.tb01440.x. [DOI] [PubMed] [Google Scholar]
  197. Whitlock C. A., Witte O. N. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3608–3612. doi: 10.1073/pnas.79.11.3608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Whitlock C. A., Witte O. N. Long-term culture of murine bone marrow precursors of B lymphocytes. Methods Enzymol. 1987;150:275–286. doi: 10.1016/0076-6879(87)50085-4. [DOI] [PubMed] [Google Scholar]
  199. Williams N., Jackson H., Meyers P. Isolation of pluripotent hemopoietic stem cells and clonable precursor cells of erythrocytes, granulocytes, macrophages and megakaryocytes from mouse bone marrow. Exp Hematol. 1979 Nov;7(10):524–534. [PubMed] [Google Scholar]
  200. Williams N., Jackson H., Sheridan A. P., Murphy M. J., Jr, Elste A., Moore M. A. Regulation of megakaryopoiesis in long-term murine bone marrow cultures. Blood. 1978 Feb;51(2):245–255. [PubMed] [Google Scholar]
  201. Wittels B. Bone marrow biopsy changes following chemotherapy for acute leukemia. Am J Surg Pathol. 1980 Apr;4(2):135–142. doi: 10.1097/00000478-198004000-00005. [DOI] [PubMed] [Google Scholar]
  202. Wu A. M., Siminovitch L., Till J. E., McCulloch E. A. Evidence for a relationship between mouse hemopoietic stem cells and cells forming colonies in culture. Proc Natl Acad Sci U S A. 1968 Apr;59(4):1209–1215. doi: 10.1073/pnas.59.4.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Xu C. X., Hendry J. H., Testa N. G. The response of stromal progenitor cells in mouse marrow to graded repeated doses of X rays or neutrons. Radiat Res. 1983 Oct;96(1):82–89. [PubMed] [Google Scholar]
  204. Yamaoka K. A., Miyasaka N., Inuo G., Saito I., Kolb J. P., Fujita K., Kashiwazaki S. 1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant. J Clin Immunol. 1994 Jan;14(1):50–60. doi: 10.1007/BF01541175. [DOI] [PubMed] [Google Scholar]
  205. Young G. A., Croaker G., Vincent P. C., Forrest P., Morris T. C. The CFU-C assay in patients with neutropenia and, in particular, drug associated neutropenia. Clin Lab Haematol. 1987;9(3):245–253. doi: 10.1111/j.1365-2257.1987.tb00088.x. [DOI] [PubMed] [Google Scholar]
  206. Zauli G., Vitale L., Brunelli M. A., Bagnara G. P. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood. Exp Hematol. 1992 Aug;20(7):850–854. [PubMed] [Google Scholar]
  207. Zhu H., Li Y., Trush M. A. Characterization of benzo[a]pyrene quinone-induced toxicity to primary cultured bone marrow stromal cells from DBA/2 mice: potential role of mitochondrial dysfunction. Toxicol Appl Pharmacol. 1995 Jan;130(1):108–120. doi: 10.1006/taap.1995.1015. [DOI] [PubMed] [Google Scholar]
  208. Zijlmans J. M., Visser J. W., Kleiverda K., Kluin P. M., Willemze R., Fibbe W. E. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8901–8905. doi: 10.1073/pnas.92.19.8901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. van der Veen J. P., Goldschmeding R., Miedema F., Smit J. W., Melief C. J., von dem Borne A. E. K-cell lymphocytosis/neutropenia syndrome: the neutropenia is not caused by autoimmunity. Br J Haematol. 1986 Dec;64(4):777–787. doi: 10.1111/j.1365-2141.1986.tb02240.x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES